1. Validated reagents for in vivo cell depletion
- Anti-asialo GM1 (αAGM1, 014-09801, FujiFilm Wako Pure Chemical Corporation), 20 μg/dose
- Rabbit IgG isotype control (Thermo Fisher Scientific), 20 μg/dose
- Anti-CD200R3 (Ba103; Hycult Biotech, Uden, the Netherlands), 30 μg /dose
- Rat IgG2b isotype control (RTK4530; BioLegend), 30 μg /dose
- Anti-Ly6G (1A8; BioLegend), 200 μg/dose
- Rat IgG2a isotype control (RTK2758; BioLegend), 200 μg/dose
- Clodronate liposome (Hygieia Bioscience), 50 mg/kg
- Control liposome (Hygieia Bioscience), 50 mg/kg
2. Reagents for flow cytometery (All from BioLegend, 1/200 dilution except for secondary antibody)
- NK cells
APC-Cy7 anti-CD3 (145–2C11) and PerCP-Cy5.5 anti-NK1.1 (PK136) - Basophils
PE anti-c-Kit (2B8) and APC anti-CD49b (DX5) - Macrophages
PE anti-F4/80 (BM8) and APC anti-CD11b (M1/70) - Neutrophils
Ly-6G (1A8), FITC Goat anti-rat IgG (1/500 dilution), and PE anti-CD11b (M1/70)
3. In vivo depletion protocol
- Dilute reagents in sterile PBS and keep on ice until use.
- Inject 200 µL of antibody solution intraperitoneally on the first and/or second day before tumor cell injection.
- For αAGM1, two doses before tumor inoculation give better depletion efficiency.
- For some experiments that need cell depletion for two weeks, inject antibody on Day -1, 0, and 7 post tumor injection.
4. Validation of the depletion efficiency
- Dissect lungs and/or spleen from the mice.
a. Preparation of a single-cell suspension of the lung cells
i. Mince the resected lungs with scissors and incubate the tissue in 10 mL of RPMI containing 200 U/mL collagenase type IV (Lakewood) and 5 U/mL DNase I (Roche) for 30 min at 37°C.
ii. Place a ϕ40-μm cell strainer (BD Bioscience) on a 50 mL tube.
iii. Transfer the cell suspension to the strainer placed in the 50 mL tube.
iv. Centrifugation at 500×g for 5 min at 4℃.
v. Resuspend with 10 mL of PBS.
vi. Centrifugation at 500×g for 5 min at 4℃.
b. Preparation of a single-cell suspension of the splenocytes
i. Place a ϕ40-μm cell strainer on a 10 cm dish containing 10 mL of PBS.
ii. Put a spleen on the cell strainer.
iii. Gently mash the spleen with the rubber end of a plunger of a 5 mL syringe.
iv. Place a ϕ40-μm cell strainer on a 50 mL tube.
v. Transfer the cell suspension to the 50 mL tube.
vi. Centrifugation at 500×g for 5 min at 4℃.
vii. Remove the strainer, discard the supernatant, and add 1 mL of ACK lysing buffer (155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA).
viii. Leave the cell suspension for 2 min on ice.
ix. Add 10 mL PBS.
x. Transfer the cell suspension in a ϕ40-μm cell strainer placed on a 50 mL tube.
xi. Centrifugation at 500×g for 5 min at 4℃.
- Cell surface staining (NK cells, basophils, and macrophages)
i. 3×105 cells were suspended with 50 μL of PBS containing 2 % BSA and diluted antibodies.
ii. Leave the cell suspension for 20 min in 4 ℃.
iii. Add 1 mL of PBS containing 2 % BSA.
iv. Centrifuge at 500×g for 5 min at 4℃.
v. Resuspend with 300 uL of PBS containing 2 % BSA.
vi. Analyze by flow cytometry.
- Intracellular staining (Neutrophils)
- Resuspend 3×105 cells with 100 μL of BD cytofix/cytoparm solution (BD Bioscience) and leave for 15 min at 4 ℃.
- Add 1 mL of BD perm/wash buffer (BD Bioscience).
- Centrifuge at 800×g for 5 min at 4℃.
- Resuspend cells with 50 μL BD perm/wash containing Ly6G antibody.
- Leave the cell suspension for 20 min at 4 ℃.
- Add 1 mL of BD perm/wash buffer and centrifuge at 800×g for 5 min at 4℃.
- Repeat the wash three times.
- Resuspend with 50 μL BD perm/wash buffer containing FITC Goat anti-rat IgG antibody for 20 min at 4℃.
- Add 1 mL BD perm/wash buffer and centrifuge at 800×g for 5 min at 4℃.
- Repeat the wash three times.
- Resuspend with 50 μL BD perm/wash buffer with anti-CD11b antibody for 20 min at 4℃.
- Add 1 mL of BD perm/wash buffer solution and centrifuge at 800×g for 5 min at 4℃.
- Repeat the wash three times.
- Resuspend with 300 μL of PBS containing 2 % BSA.
- Analyze by flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.